The role of formulation on the pharmacokinetics of antiretroviral drugs.
about
The Need for Pediatric Formulations to Treat Children with HIVDose evaluation of lamivudine in human immunodeficiency virus-infected children aged 5 months to 18 years based on a population pharmacokinetic analysis.Simulating Intestinal Transporter and Enzyme Activity in a Physiologically Based Pharmacokinetic Model for Tenofovir Disoproxil Fumarate.A HAART-Breaking Review of Alternative Antiretroviral Administration: Practical Considerations with Crushing and Enteral Tube Scenarios.Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Relationships of Etravirine in HIV-1-Infected, Treatment-Experienced Children and Adolescents in PIANO.Effect of Sorbitol on the Pharmacokinetic Profile of Lamivudine Oral Solution in Adults: An Open-Label, Randomized Study.
P2860
The role of formulation on the pharmacokinetics of antiretroviral drugs.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The role of formulation on the pharmacokinetics of antiretroviral drugs.
@en
type
label
The role of formulation on the pharmacokinetics of antiretroviral drugs.
@en
prefLabel
The role of formulation on the pharmacokinetics of antiretroviral drugs.
@en
P2093
P2860
P1476
The role of formulation on the pharmacokinetics of antiretroviral drugs
@en
P2093
David M Burger
Diane E T Bastiaans
Herman Vromans
P2860
P304
P356
10.1517/17425255.2014.925879
P407
P577
2014-05-30T00:00:00Z